Target intelligence / Profile preview

Sodium- and chloride-dependent creatine transporter 1 (SLC6A8) (SLC6A8)

Target
SLC6A8
Molecular classification
Transporter, Solute carrier superfamily, SLC6 family
01

Overview

Sodium- and chloride-dependent creatine transporter 1 (SLC6A8) is a multi-pass membrane protein belonging to the solute carrier family 6. It plays a critical role in cellular energy homeostasis by mediating the uptake of creatine into cells, particularly in high-energy-demand tissues such as the brain, skeletal muscle, and heart. By facilitating the transport of creatine, the protein helps maintain the intracellular phosphocreatine pool required for rapid ATP regeneration.

Mutations in the SLC6A8 gene lead to X-linked creatine transporter deficiency (CTD), a severe neurodevelopmental disorder characterized by intellectual disability, speech delay, and seizures. Conversely, SLC6A8 is overexpressed in certain cancers, such as colorectal cancer, where it supports tumor survival and metastasis in hypoxic environments by supplying creatine for ATP generation. Therapeutic strategies targeting SLC6A8 include competitive inhibitors like ompenaclid (RGX-202) to starve cancer cells of energy, as well as gene therapy and pharmacochaperone approaches to restore transporter function in patients with CTD.

Other names
Creatine transporter 1CT1Solute carrier family 6 member 8CRTCRTR
02

Mechanism of action

Competitive inhibition of creatine transport

03

Biological functions

Creatine transmembrane transportSodium ion transportChloride ion transportCellular energy homeostasisATP buffering
04

Disease associations

CancerColorectal cancerCerebral creatine deficiency syndrome 1X-linked creatine transporter deficiencyIntellectual disabilitySeizures
05

Safety considerations

Systemic energy depletion in high-demand tissues (brain, skeletal muscle, heart)Potential neurotoxicity or cognitive impairmentMuscle weakness or crampsRenal dysfunction or altered creatinine clearance assessment
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Urinary creatine/creatinine ratioBrain creatine levels (measured by 1H-MRS)Tumoral creatine kinase B (CKB) expressionUrinary creatine excretion

Beyond the preview

Go deeper on Sodium- and chloride-dependent creatine transporter 1 (SLC6A8) (SLC6A8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium- and chloride-dependent creatine transporter 1 (SLC6A8) (SLC6A8).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call